Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting.

  • Authors : Yen HH; Division of Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Subjects: Sustained Virologic Response*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: PloS one [PLoS One] 2020 Aug 13; Vol. 15 (8), pp. e0237582. Date of Electronic Publication: 2020 Aug 13 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.

  • Authors : Huang CF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Kuo HT

Subjects: Aminoisobutyric Acids/Aminoisobutyric Acids/Aminoisobutyric Acids/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: Scientific reports [Sci Rep] 2021 Dec 06; Vol. 11 (1), pp. 23473. Date of Electronic Publication: 2021 Dec 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.

  • Authors : Townshend-Bulson L; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.; Roik E

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Carbamates/Carbamates/Carbamates/*therapeutic use

  • Source: PloS one [PLoS One] 2021 Dec 02; Vol. 16 (12), pp. e0260970. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis.

  • Authors : Yang X; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Tang Y

Subjects: Drug Users* ; Hepatitis C*/Hepatitis C*/Hepatitis C*/drug therapy; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Virology journal [Virol J] 2021 Jul 27; Vol. 18 (1), pp. 156. Date of Electronic Publication: 2021 Jul 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

Record details

×
Academic Journal

Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.

  • Authors : Umemura M; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.; Suda G

Subjects: Aminoisobutyric Acids/Aminoisobutyric Acids/Aminoisobutyric Acids/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage

  • Source: BMC infectious diseases [BMC Infect Dis] 2021 Apr 27; Vol. 21 (1), pp. 389. Date of Electronic Publication: 2021 Apr 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Academic Journal

Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report.

  • Authors : Aldunate F; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay.; Laboratorio de Evolución Experimental de Virus, Institut Pasteur de Montevideo, Mataojo 2020, ZIP: 11400, Montevideo, Uruguay.

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

  • Source: BMC infectious diseases [BMC Infect Dis] 2021 Apr 26; Vol. 21 (1), pp. 387. Date of Electronic Publication: 2021 Apr 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Academic Journal

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection.

  • Authors : Younossi ZM; Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia.; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.

Subjects: Quality of Life* ; Sustained Virologic Response*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Journal of viral hepatitis [J Viral Hepat] 2018 Dec; Vol. 25 (12), pp. 1429-1437. Date of Electronic Publication: 2018 Aug 22.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Report

Treatment of chronic hepatitis C with sofosbuvir in a hemodialysis patient: a case report.

  • Authors : Tchoupe MD; Nephrology Department, Faculty of Medicine, Hedi Chaker University Hospital and UR 12ES14, Sfax, Tunisia.; Chaker H

Subjects: Renal Dialysis*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*administration & dosage

  • Source: The Pan African medical journal [Pan Afr Med J] 2021 Feb 08; Vol. 38, pp. 137. Date of Electronic Publication: 2021 Feb 08 (Print Publication: 2021).Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study.

  • Authors : Gheorghe LS; Carol Davila University of Medicine and Pharmacy, Gastroenterol and Hepatol Depart, Clinic Fundeni Institute, Bucharest, Romania. . .; Preda C

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Fluorenes/Fluorenes/Fluorenes/*therapeutic use

  • Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2020 Sep 09; Vol. 29 (3), pp. 385-390. Date of Electronic Publication: 2020 Sep 09.Publisher:

Record details

×
Academic Journal

Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment.

  • Authors : Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.

Subjects: Hepatitis C, Chronic*/Hepatitis C, Chronic*/Hepatitis C, Chronic*/drug therapy; Aminoisobutyric Acids/Aminoisobutyric Acids/Aminoisobutyric Acids/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Journal of viral hepatitis [J Viral Hepat] 2020 Jun; Vol. 27 (6), pp. 568-575. Date of Electronic Publication: 2020 Feb 06.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  610 results for ""Sustained Virologic Response""